Table 1. Baseline characters and demographics of sarcomatoid lung cancer patients (n = 25).

Patient	Age (years)	Gender	Race	Smoking, (PPY)
Pt_1	57	M	AA	Smoker, 40
Pt_2	56	M	W	Smoker, 40
Pt_3	56	F	W	Non-smoker
Pt_4	31	F	W	Smoker, 43
Pt_5	76	M	W	Smoker, 43
Pt_6	51	M	W	Smoker, 60
Pt_7	73	F	W	Smoker, 54
Pt_8	83	M	W	Smoker, 70
Pt_9	62	M	W	Smoker, 40
Pt_10	47	M	W	Smoker, 20
Pt_11	51	M	AA	Smoker, 50
Pt_12	68	F	W	Smoker, 50
Pt_13	69	M	W	Non-smoker
Pt_14	66	M	W	Smoker, 56
Pt_15	68	M	W	Smoker, 45
Pt_16	57	M	W	Smoker, 40
Pt_17	67	F	W	Smoker, 50
Pt_18	54	M	AA	Smoker, 38
Pt_19	84	F	W	Non-smoker
Pt_20	57	F	W	Smoker, 36
Pt_21	71	M	W	Smoker, 43
Pt_22	54	M	W	Non-smoker
Pt_23	70	M	W	Smoker, 56
Pt_24	59	F	AA	Smoker, 40
Pt_25	59	F	W	Smoker, 50

Abbreviations: EGFR, epidermal growth factor receptor;

EML-4/ALK, echinoderm-like microtubule-like protein-4/anaplastic lymphoma kinase; HR, hazard ratio;

NSCLC, non-small cell lung cancer;

PSC, pulmonary sarcomatoid carcinoma;

OS, overall survival,

M: male, F: female, W: white American, AA: African American,

PPY: Pack per year.

Pt: patient.